Celine Desvignes
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics.
Journal: Clinical pharmacokinetics
Published: July 06, 2025
Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update.
Journal: Basic & clinical pharmacology & toxicology
Published: May 23, 2025
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Journal: Experimental hematology & oncology
Published: March 12, 2024
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.
Journal: British journal of clinical pharmacology
Published: October 18, 2023
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.
Journal: British journal of clinical pharmacology
Published: September 25, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Journal: Journal of internal medicine
Published: August 18, 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.
Journal: Clinical pharmacokinetics
Published: May 28, 2023
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition.
Journal: Clinical pharmacokinetics
Published: October 05, 2021
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model.
Journal: Pharmaceutics
Published: September 14, 2021
Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells.
Journal: Biomarkers in medicine
Published: June 25, 2021
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.
Journal: International journal of molecular sciences
Published: April 09, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations.
Journal: Bioanalysis
Published: March 26, 2021
Last Updated: 09/26/2026